Work

Assessment of Durable Responses after Brexucabtagene Autoleucel (KTE-X19) in the ZUMA-2 Study in Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-158097

Authors: Javier Munoz, Patrick M. Reagan, Andre H. Goy, David B. Miklos, Dan Zheng, Xiang Fang, Rhine R. Shen, Rubina Siddiqi, Ioana Kloos, Marie José Kersten, Michael Wang

Institutions: Banner MD Anderson Cancer Center, University of Rochester Medicine, University of Rochester, Stanford University, Hovon, Amsterdam University Medical Centers, University of Amsterdam, The University of Texas MD Anderson Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310120218

FWCI: 0.105

Cites:

Cited by: 2

Related to: 10